Correvio Pharma

Correvio Pharma is a specialty pharmaceutical company engaged in developing therapeutics. It commercializes cardiology products, including Brinavess (vernakalant HCl, IV) for the conversion of recent-onset atrial fibrillation to sinus rhythm in adults; Aggrastat (tirofiban HCl), a reversible GP IIb/IIIa inhibitor for use in patients with the acute coronary syndrome (ACS); Esmocard and Esmocard Lyo (esmolol hydrochloride), a short-acting beta-blocker used to control rapid heart rate. In addition, the company offers drugs for pulmonary arterial hypertension, acute bacterial skin infections, and more.